Works by Gormsen, Lars C.


Results: 56
    1

    Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2264, doi. 10.1111/dom.13362
    By:
    • Breining, Peter;
    • Jensen, Jonas B.;
    • Sundelin, Elias I.;
    • Gormsen, Lars C.;
    • Jakobsen, Steen;
    • Busk, Morten;
    • Rolighed, Lars;
    • Bross, Peter;
    • Fernandez‐Guerra, Paula;
    • Markussen, Lasse K.;
    • Rasmussen, Nanna E.;
    • Hansen, Jacob B.;
    • Pedersen, Steen B.;
    • Richelsen, Bjørn;
    • Jessen, Niels
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    Myocardial Perfusion Imaging Versus Computed Tomography Angiography–Derived Fractional Flow Reserve Testing in Stable Patients With Intermediate‐Range Coronary Lesions: Influence on Downstream Diagnostic Workflows and Invasive Angiography Findings.

    Published in:
    Journal of the American Heart Association, 2017, v. 6, n. 8, p. 1, doi. 10.1161/JAHA.117.005587
    By:
    • Nørgaard, Bjarne L.;
    • Gormsen, Lars C.;
    • Bøtker, Hans Erik;
    • Parner, Erik;
    • Nielsen, Lene H.;
    • Mathiassen, Ole N.;
    • Grove, Erik L.;
    • Øvrehus, Kristian A.;
    • Gaur, Sara;
    • Leipsic, Jonathon;
    • Pedersen, Kamilla;
    • Terkelsen, Christian J.;
    • Christiansen, Evald H.;
    • Kaltoft, Anne;
    • Mæng, Michael;
    • Kristensen, Steen D.;
    • Krusell, Lars R.;
    • Lassen, Jens F.;
    • Jensen, Jesper M.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    PET/MRI in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM) and the EANM Forschungs GmbH (EARL).

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2927, doi. 10.1007/s00259-023-06308-y
    By:
    • Prakken, Niek H. J.;
    • Besson, Florent L.;
    • Borra, Ronald J. H.;
    • Büther, Florian;
    • Buechel, Ronny R.;
    • Catana, Ciprian;
    • Chiti, Arturo;
    • Dierckx, Rudi A. J. O.;
    • Dweck, Marc R.;
    • Erba, Paola A.;
    • Glaudemans, Andor W. J. M.;
    • Gormsen, Lars C.;
    • Hristova, Ivalina;
    • Koole, Michel;
    • Kwee, Thomas C.;
    • Mottaghy, Felix M.;
    • Polycarpou, Irene;
    • Prokop, Mathias;
    • Stegger, Lars;
    • Tsoumpas, Charalampos
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetes.

    Published in:
    Basic & Clinical Pharmacology & Toxicology, 2024, v. 134, n. 5, p. 643, doi. 10.1111/bcpt.13991
    By:
    • Voigt, Jens Hohwü;
    • Lauritsen, Katrine M.;
    • Pedersen, Steen Bønløkke;
    • Hansen, Troels K.;
    • Møller, Niels;
    • Jessen, Niels;
    • Laurenti, Marcello C.;
    • Man, Chiara Dalla;
    • Vella, Adrian;
    • Gormsen, Lars C.;
    • Søndergaard, Esben
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50